Featured Research

from universities, journals, and other organizations

Aspirin May Not Be Strong Enough To Prevent Clots In Some Heart Patients

Date:
November 13, 2003
Source:
Johns Hopkins Medical Institutions
Summary:
While an aspirin a day helps keep a heart attack at bay, it may need reinforcement to totally prevent blood clots among patients with chest pain, a Johns Hopkins study shows.

While an aspirin a day helps keep a heart attack at bay, it may need reinforcement to totally prevent blood clots among patients with chest pain, a Johns Hopkins study shows.

Researchers took blood samples from 33 patients hospitalized for chest pain at Johns Hopkins Bayview Medical Center. Eighteen patients had acute coronary syndrome, or heart-disease-related chest pain, and 15 had non-cardiac chest pain. All took aspirin at 81 to 325 milligrams per day.

The Hopkins team treated the samples with very low doses of ADP and epinephrine – medications that allow platelets, tiny disk-shaped structures within the blood, to clump together. They found that despite treatment with aspirin, platelets clotted together 5 percent to 10 percent more among the patients with heart disease than those without.

The work is to be presented Nov. 10 at the American Heart Association's 76th Scientific Sessions in Orlando, Fla.

"Even though these patients were receiving aspirin therapy, they still had very active platelets," says Marlene S. Williams, M.D., lead author of the study and assistant professor of medicine. The more the platelets clump together, the higher the chance of a clot forming, leading to a heart attack, she says.

Patients already taking daily aspirin should continue, Williams says. Her further studies will investigate the addition of other anti-clotting agents to aspirin therapy, and the study of abnormal genes that might affect platelet function.

###

The study was funded by the National Institutes of Health. Coauthors were David E. Bush, M.D., and Thomas Kickler, M.D.

Abstract #1756: Williams, M.S., "Platelet Hyperreactivity Is Present in Acute Coronary Syndromes Despite Treatment with Aspirin."

Related links:

Johns Hopkins' Division of Cardiologyhttp://www.hopkinsmedicine.org/cardiology/

American Heart Association - 76th Scientific Sessionshttp://www.scientificsessions.org/


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Aspirin May Not Be Strong Enough To Prevent Clots In Some Heart Patients." ScienceDaily. ScienceDaily, 13 November 2003. <www.sciencedaily.com/releases/2003/11/031113070022.htm>.
Johns Hopkins Medical Institutions. (2003, November 13). Aspirin May Not Be Strong Enough To Prevent Clots In Some Heart Patients. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2003/11/031113070022.htm
Johns Hopkins Medical Institutions. "Aspirin May Not Be Strong Enough To Prevent Clots In Some Heart Patients." ScienceDaily. www.sciencedaily.com/releases/2003/11/031113070022.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins